The Global Beta Glucan Market was valued at USD 488.3 million in 2025 and is estimated to grow at a CAGR of 8.8% to reach USD 1.1 billion by 2035.
Market expansion is linked to growing awareness of the physiological benefits associated with beta glucan and its widening use across food, nutrition, and pharmaceutical applications. Beta glucan is positioned as a naturally derived dietary fiber recognized for supporting immune response, managing cholesterol levels, and assisting in balanced carbohydrate metabolism. Its role in promoting heart health and immune defense has strengthened its adoption in wellness-focused product formulations. Consumers are increasingly inclined toward naturally sourced health ingredients, further reinforcing demand. Additional benefits related to blood sugar management and antioxidant activity continue to support its relevance in long-term health management. From a commercial perspective, manufacturers are broadening application areas, with beta glucan increasingly incorporated into food and beverage formulations aimed at health-conscious buyers. This diversification, combined with scientific validation and product innovation, is sustaining strong global market momentum.
The cereal grain-based beta glucan segment accounted for 46.6% share in 2025 and is forecast to grow at a CAGR of 8.9% through 2035. This segment benefits from long-term consumer acceptance of plant-derived functional ingredients and steady improvements in extraction efficiency. Advances in processing technologies are enhancing product purity and consistency, while clean-label preferences are encouraging the use of responsibly sourced raw materials. Supportive regulatory frameworks across developed markets continue to strengthen adoption and commercial scalability.
The soluble form of beta glucan held a 57.4% share in 2025 and is expected to grow at a CAGR of 8.9% from 2026 to 2035. This category is widely used due to its high functional performance, improved absorption, and suitability for nutritional formulations targeting cardiovascular wellness, immune support, and glucose regulation. Enhanced bioavailability contributes to its effectiveness and sustained demand across multiple application segments.
North America Beta Glucan Market held 38.8% share in 2025, making it the leading regional contributor. Market growth in the region is driven by strong consumer engagement with wellness-focused products and increasing incorporation of functional ingredients across food, supplement, and pharmaceutical categories. Emphasis on immune health, heart health, and weight management continues to support product development, while demand for clean-label and plant-based formulations remains high.
Key companies operating in the Global Beta Glucan Market include DSM, Kerry, Tate & Lyle PLC, Givaudan, Angel Yeast, Lallemand, Kemin Industries, Lantmännen Biorefineries, Leiber GmbH, Biorigin S.A., Ohly, Super Beta Glucan, and VW-Ingredients. Companies in the Global Beta Glucan Market are strengthening their competitive position through innovation-driven product development and strategic capacity expansion. Leading players are investing in advanced processing technologies to improve yield, consistency, and functional performance. Strategic collaborations with food, nutrition, and pharmaceutical manufacturers are helping companies expand application reach and secure long-term supply agreements. Firms are also focusing on clean-label positioning, sustainability commitments, and transparent sourcing to align with evolving consumer expectations.
This product will be delivered within 2-4 business days.
Market expansion is linked to growing awareness of the physiological benefits associated with beta glucan and its widening use across food, nutrition, and pharmaceutical applications. Beta glucan is positioned as a naturally derived dietary fiber recognized for supporting immune response, managing cholesterol levels, and assisting in balanced carbohydrate metabolism. Its role in promoting heart health and immune defense has strengthened its adoption in wellness-focused product formulations. Consumers are increasingly inclined toward naturally sourced health ingredients, further reinforcing demand. Additional benefits related to blood sugar management and antioxidant activity continue to support its relevance in long-term health management. From a commercial perspective, manufacturers are broadening application areas, with beta glucan increasingly incorporated into food and beverage formulations aimed at health-conscious buyers. This diversification, combined with scientific validation and product innovation, is sustaining strong global market momentum.
The cereal grain-based beta glucan segment accounted for 46.6% share in 2025 and is forecast to grow at a CAGR of 8.9% through 2035. This segment benefits from long-term consumer acceptance of plant-derived functional ingredients and steady improvements in extraction efficiency. Advances in processing technologies are enhancing product purity and consistency, while clean-label preferences are encouraging the use of responsibly sourced raw materials. Supportive regulatory frameworks across developed markets continue to strengthen adoption and commercial scalability.
The soluble form of beta glucan held a 57.4% share in 2025 and is expected to grow at a CAGR of 8.9% from 2026 to 2035. This category is widely used due to its high functional performance, improved absorption, and suitability for nutritional formulations targeting cardiovascular wellness, immune support, and glucose regulation. Enhanced bioavailability contributes to its effectiveness and sustained demand across multiple application segments.
North America Beta Glucan Market held 38.8% share in 2025, making it the leading regional contributor. Market growth in the region is driven by strong consumer engagement with wellness-focused products and increasing incorporation of functional ingredients across food, supplement, and pharmaceutical categories. Emphasis on immune health, heart health, and weight management continues to support product development, while demand for clean-label and plant-based formulations remains high.
Key companies operating in the Global Beta Glucan Market include DSM, Kerry, Tate & Lyle PLC, Givaudan, Angel Yeast, Lallemand, Kemin Industries, Lantmännen Biorefineries, Leiber GmbH, Biorigin S.A., Ohly, Super Beta Glucan, and VW-Ingredients. Companies in the Global Beta Glucan Market are strengthening their competitive position through innovation-driven product development and strategic capacity expansion. Leading players are investing in advanced processing technologies to improve yield, consistency, and functional performance. Strategic collaborations with food, nutrition, and pharmaceutical manufacturers are helping companies expand application reach and secure long-term supply agreements. Firms are also focusing on clean-label positioning, sustainability commitments, and transparent sourcing to align with evolving consumer expectations.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Extract, 2022-2035 (USD Million) (Kilo Tons)
Chapter 6 Market Estimates and Forecast, by Form, 2022-2035 (USD Million) (Kilo Tons)
Chapter 7 Market Estimates and Forecast, by Application, 2022-2035 (USD Million) (Kilo Tons)
Chapter 8 Market Estimates and Forecast, by Region, 2022-2035 (USD Million) (Kilo Tons)
Chapter 9 Company Profiles
Companies Mentioned
The companies profiled in this Beta Glucan market report include:- Angel Yeast
- Biorigin S.A.
- DSM
- Givaudan
- Kemin Industries
- Kerry
- Lallemand
- Lantmännen Biorefineries
- Leiber GmbH
- Ohly
- Super Beta Glucan
- Tate & Lyle PLC
- VW-Ingredients
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 190 |
| Published | December 2025 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 488.3 Million |
| Forecasted Market Value ( USD | $ 1100 Million |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
